17 studies found for:    Premenstrual Syndrome: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Premenstrual Syndrome: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
Condition: Premenstrual Syndrome
Interventions: Drug: extracts of Vitex agnus castus tablets;   Drug: Placebo
2 Recruiting Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Conditions: Premenstrual Syndrome;   Mastodynia
Interventions: Drug: 20mg VAC BNO 1095 FCT;   Drug: Placebo
3 Completed Auriculotherapy in the Cares to the Premenstrual Syndrome
Condition: Premenstrual Syndrome
Intervention: Other: Auriculotherapy group
4 Completed Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
Condition: Pelvic Organ Prolapse
Interventions: Procedure: SSLF;   Procedure: ULS;   Behavioral: PMT
5 Completed Athena Pelvic Muscle Trainer - DUETS Trial
Condition: Urinary Incontinence
Intervention: Device: Athena Pelvic Muscle Trainer
6 Completed Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Conditions: Premenstrual Syndrome;   Menstruation Disturbances
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
7 Active, not recruiting Treatment of Severe Childhood Aggression (The TOSCA Study)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Methylphenidate HCl;   Drug: Risperidone;   Behavioral: Parent Management Training (PMT);   Drug: Placebo
8 Withheld [Trial of device that is not approved or cleared by the U.S. FDA]
Condition:
Intervention:
9 Recruiting Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Condition: Borderline Personality Disorder
Interventions: Drug: Selegiline;   Drug: Placebo (for Selegiline)
10 Recruiting A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors And in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Condition: Solid Cancers
Interventions: Drug: GDC-0032;   Drug: fulvestrant;   Drug: letrozole
11 Active, not recruiting Atomoxetine, Placebo and Parent Management Training in Autism
Conditions: Autism;   Pervasive Development Disorder;   Asperger's Disorder;   Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine;   Drug: Placebo;   Behavioral: Parent Management Training
12 Unknown  Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Condition: Premenstrual Dysphoric Disorder
Interventions: Drug: PH80;   Drug: Placebo intranasal spray
13 Completed Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Intervention: Drug: Levetiracetam
14 Completed Luteal Phase Administration of Paroxetine for the Treatment of PMDD
Condition: Premenstrual Dysphoric Disorder
Intervention: Drug: Paroxetine
15 Completed Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Drug: oral microencapsulated diindolylmethane;   Genetic: polymerase chain reaction;   Other: cervical Papanicolaou test;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy
16 Active, not recruiting Impact of Hot Flashes on Sleep and Mood Disturbance
Conditions: Menopause;   Depression;   Hot Flashes
Intervention: Drug: Leuprolide
17 Recruiting Foster Teens' Risk During Transition
Conditions: School Adjustment;   Foster Care Disruptions
Intervention: Behavioral: LINKS

Indicates status has not been verified in more than two years